STOCK TITAN

[Form 4] SLM Corporation Insider Trading Activity

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Form 4 overview: Independent director Mary Carter Warren Franke reported receiving 5,281 shares of SLM Corp. restricted common stock on 06/17/2025 under the company’s 2021 Omnibus Incentive Plan. The award, valued at $0 exercise price, represents a portion of the annual director retainer and is subject to vesting conditions outlined in the 2025 Independent Director Restricted Stock Agreement. Following the grant, the director’s direct beneficial ownership increased to 97,532.9277 shares; an additional 7,000 shares are held indirectly through the spouse’s IRA. The filing contains no derivative transactions, sales, or purchases for cash consideration, indicating this is a routine equity-based compensation grant rather than a market-driven trade.

Investor takeaway: The transaction modestly increases insider equity alignment but does not signal a change in sentiment or fundamentals for SLM (ticker: SLM). Given the small absolute share count versus SLM’s ~250 million shares outstanding, market impact is expected to be immaterial.

Panoramica del Modulo 4: La direttrice indipendente Mary Carter Warren Franke ha dichiarato di aver ricevuto 5.281 azioni di azioni ordinarie ristrette di SLM Corp. il 17/06/2025 nell’ambito del Piano Incentivi Omnibus 2021 della società. Il premio, valutato con un prezzo di esercizio pari a $0, rappresenta una parte del compenso annuale per i direttori ed è soggetto alle condizioni di maturazione previste nell’Accordo sulle Azioni Ristrette per Direttori Indipendenti 2025. Dopo l’assegnazione, la proprietà diretta effettiva della direttrice è aumentata a 97.532,9277 azioni; ulteriori 7.000 azioni sono detenute indirettamente tramite l’IRA del coniuge. La dichiarazione non riporta transazioni derivate, vendite o acquisti a fronte di un corrispettivo in denaro, indicando che si tratta di una normale assegnazione di compensi basata su azioni e non di un’operazione di mercato.

Considerazioni per l’investitore: La transazione aumenta leggermente l’allineamento patrimoniale degli insider, ma non segnala un cambiamento nel sentiment o nei fondamentali di SLM (ticker: SLM). Considerando il numero assoluto di azioni relativamente basso rispetto alle circa 250 milioni di azioni in circolazione di SLM, l’impatto sul mercato è previsto come irrilevante.

Resumen del Formulario 4: La directora independiente Mary Carter Warren Franke informó haber recibido 5,281 acciones de acciones comunes restringidas de SLM Corp. el 17/06/2025 bajo el Plan de Incentivos Omnibus 2021 de la compañía. La concesión, valorada con un precio de ejercicio de $0, representa una parte de la remuneración anual para directores y está sujeta a las condiciones de adquisición establecidas en el Acuerdo de Acciones Restringidas para Directores Independientes de 2025. Tras la concesión, la propiedad directa beneficiosa de la directora aumentó a 97,532.9277 acciones; además, 7,000 acciones se mantienen indirectamente a través de la IRA del cónyuge. La presentación no contiene transacciones derivadas, ventas ni compras con contraprestación en efectivo, lo que indica que se trata de una concesión rutinaria de compensación basada en acciones y no de una operación impulsada por el mercado.

Conclusión para el inversor: La transacción incrementa modestamente la alineación de patrimonio de los insiders, pero no indica un cambio en el sentimiento o los fundamentos de SLM (símbolo: SLM). Dado el pequeño número absoluto de acciones en comparación con las aproximadamente 250 millones de acciones en circulación de SLM, se espera que el impacto en el mercado sea insignificante.

서식 4 개요: 독립 이사 Mary Carter Warren Franke는 2025년 6월 17일 회사의 2021년 총괄 인센티브 플랜에 따라 SLM Corp.의 제한된 보통주 5,281주를 수령했다고 보고했습니다. 이 수여는 행사가격 $0로 평가되며 연간 이사 보수의 일부를 나타내며 2025년 독립 이사 제한 주식 계약에 명시된 권리 취득 조건이 적용됩니다. 수여 후 이사의 직접 실질 소유권97,532.9277주로 증가했으며, 추가로 7,000주는 배우자의 IRA를 통해 간접 보유 중입니다. 제출 서류에는 파생 거래, 매도 또는 현금 대가로 인한 매수 내역이 없으며, 이는 시장 주도 거래가 아닌 일상적인 주식 기반 보상 수여임을 나타냅니다.

투자자 참고사항: 이번 거래는 내부자 지분 정렬을 소폭 증가시키지만 SLM(티커: SLM)의 심리나 펀더멘털 변화 신호는 아닙니다. 약 2억 5천만 주의 발행 주식 대비 소량의 주식 수로 인해 시장 영향은 미미할 것으로 예상됩니다.

Vue d’ensemble du Formulaire 4 : La directrice indépendante Mary Carter Warren Franke a déclaré avoir reçu 5 281 actions d’actions ordinaires restreintes de SLM Corp. le 17/06/2025 dans le cadre du Plan d’Incitation Omnibus 2021 de la société. La récompense, évaluée avec un prix d’exercice de 0 $, représente une partie de la rémunération annuelle des administrateurs et est soumise aux conditions d’acquisition définies dans l’Accord d’Actions Restreintes pour Administrateurs Indépendants de 2025. Après l’attribution, la propriété bénéficiaire directe de la directrice a augmenté à 97 532,9277 actions ; 7 000 actions supplémentaires sont détenues indirectement via le IRA de son conjoint. Le dépôt ne contient aucune transaction dérivée, vente ou achat contre paiement en espèces, indiquant qu’il s’agit d’une attribution de rémunération en actions de routine plutôt que d’une opération motivée par le marché.

À retenir pour l’investisseur : La transaction augmente modestement l’alignement des intérêts des initiés, mais ne signale pas de changement de sentiment ou de fondamentaux pour SLM (symbole : SLM). Étant donné le faible nombre absolu d’actions par rapport aux quelque 250 millions d’actions en circulation de SLM, l’impact sur le marché devrait être négligeable.

Überblick Formular 4: Die unabhängige Direktorin Mary Carter Warren Franke meldete am 17.06.2025 den Erhalt von 5.281 Aktien von eingeschränkten Stammaktien der SLM Corp. im Rahmen des Omnibus-Anreizplans 2021 des Unternehmens. Die Zuteilung, bewertet mit einem Ausübungspreis von $0, stellt einen Teil der jährlichen Vergütung für Direktoren dar und unterliegt den Vesting-Bedingungen, die im Restricted Stock Agreement für unabhängige Direktoren 2025 festgelegt sind. Nach der Zuteilung erhöhte sich das direkte wirtschaftliche Eigentum der Direktorin auf 97.532,9277 Aktien; weitere 7.000 Aktien werden indirekt über das IRA-Konto des Ehepartners gehalten. Die Meldung enthält keine derivativen Transaktionen, Verkäufe oder Käufe gegen Barzahlung, was darauf hinweist, dass es sich um eine routinemäßige aktienbasierte Vergütung handelt und nicht um einen marktgetriebenen Handel.

Investorenausblick: Die Transaktion erhöht die Beteiligung der Insider geringfügig, signalisiert jedoch keine Änderung der Stimmung oder der Fundamentaldaten von SLM (Ticker: SLM). Angesichts der kleinen absoluten Aktienanzahl im Vergleich zu den rund 250 Millionen ausstehenden Aktien von SLM wird der Markteinfluss als unwesentlich eingeschätzt.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Routine director stock grant; negligible share count; no cash transaction—neutral for valuation.

The Form 4 discloses a standard restricted stock award to director Mary Carter Warren Franke. At 5,281 shares, the grant is less than 0.002% of outstanding stock and carries no purchase price, suggesting compensation, not insider conviction. Post-transaction ownership sits at ~97.5k shares, implying continued alignment but offering little signalling power. No derivative positions were exercised or disposed, and no sales occurred. Because the grant is customary for board compensation and does not reflect market timing, it should not materially affect stock supply, demand, or investor perception. Overall impact is neutral.

TL;DR: Filing shows compliant equity retainer; governance standards maintained; no red flags.

The award stems from SLM’s 2021 Omnibus Incentive Plan, reinforcing a pay-for-service structure typical for independent directors. Vesting provisions contained in the 2025 Agreement preserve retention incentives without immediate liquidity, aligning director interests with long-term shareholders. Absence of Rule 10b5-1 check marks indicates the transaction is not part of a trading plan, yet because it is a grant at zero cost, insider-trading risk is minimal. Governance posture remains sound, and there are no indications of preferential treatment or excessive compensation.

Panoramica del Modulo 4: La direttrice indipendente Mary Carter Warren Franke ha dichiarato di aver ricevuto 5.281 azioni di azioni ordinarie ristrette di SLM Corp. il 17/06/2025 nell’ambito del Piano Incentivi Omnibus 2021 della società. Il premio, valutato con un prezzo di esercizio pari a $0, rappresenta una parte del compenso annuale per i direttori ed è soggetto alle condizioni di maturazione previste nell’Accordo sulle Azioni Ristrette per Direttori Indipendenti 2025. Dopo l’assegnazione, la proprietà diretta effettiva della direttrice è aumentata a 97.532,9277 azioni; ulteriori 7.000 azioni sono detenute indirettamente tramite l’IRA del coniuge. La dichiarazione non riporta transazioni derivate, vendite o acquisti a fronte di un corrispettivo in denaro, indicando che si tratta di una normale assegnazione di compensi basata su azioni e non di un’operazione di mercato.

Considerazioni per l’investitore: La transazione aumenta leggermente l’allineamento patrimoniale degli insider, ma non segnala un cambiamento nel sentiment o nei fondamentali di SLM (ticker: SLM). Considerando il numero assoluto di azioni relativamente basso rispetto alle circa 250 milioni di azioni in circolazione di SLM, l’impatto sul mercato è previsto come irrilevante.

Resumen del Formulario 4: La directora independiente Mary Carter Warren Franke informó haber recibido 5,281 acciones de acciones comunes restringidas de SLM Corp. el 17/06/2025 bajo el Plan de Incentivos Omnibus 2021 de la compañía. La concesión, valorada con un precio de ejercicio de $0, representa una parte de la remuneración anual para directores y está sujeta a las condiciones de adquisición establecidas en el Acuerdo de Acciones Restringidas para Directores Independientes de 2025. Tras la concesión, la propiedad directa beneficiosa de la directora aumentó a 97,532.9277 acciones; además, 7,000 acciones se mantienen indirectamente a través de la IRA del cónyuge. La presentación no contiene transacciones derivadas, ventas ni compras con contraprestación en efectivo, lo que indica que se trata de una concesión rutinaria de compensación basada en acciones y no de una operación impulsada por el mercado.

Conclusión para el inversor: La transacción incrementa modestamente la alineación de patrimonio de los insiders, pero no indica un cambio en el sentimiento o los fundamentos de SLM (símbolo: SLM). Dado el pequeño número absoluto de acciones en comparación con las aproximadamente 250 millones de acciones en circulación de SLM, se espera que el impacto en el mercado sea insignificante.

서식 4 개요: 독립 이사 Mary Carter Warren Franke는 2025년 6월 17일 회사의 2021년 총괄 인센티브 플랜에 따라 SLM Corp.의 제한된 보통주 5,281주를 수령했다고 보고했습니다. 이 수여는 행사가격 $0로 평가되며 연간 이사 보수의 일부를 나타내며 2025년 독립 이사 제한 주식 계약에 명시된 권리 취득 조건이 적용됩니다. 수여 후 이사의 직접 실질 소유권97,532.9277주로 증가했으며, 추가로 7,000주는 배우자의 IRA를 통해 간접 보유 중입니다. 제출 서류에는 파생 거래, 매도 또는 현금 대가로 인한 매수 내역이 없으며, 이는 시장 주도 거래가 아닌 일상적인 주식 기반 보상 수여임을 나타냅니다.

투자자 참고사항: 이번 거래는 내부자 지분 정렬을 소폭 증가시키지만 SLM(티커: SLM)의 심리나 펀더멘털 변화 신호는 아닙니다. 약 2억 5천만 주의 발행 주식 대비 소량의 주식 수로 인해 시장 영향은 미미할 것으로 예상됩니다.

Vue d’ensemble du Formulaire 4 : La directrice indépendante Mary Carter Warren Franke a déclaré avoir reçu 5 281 actions d’actions ordinaires restreintes de SLM Corp. le 17/06/2025 dans le cadre du Plan d’Incitation Omnibus 2021 de la société. La récompense, évaluée avec un prix d’exercice de 0 $, représente une partie de la rémunération annuelle des administrateurs et est soumise aux conditions d’acquisition définies dans l’Accord d’Actions Restreintes pour Administrateurs Indépendants de 2025. Après l’attribution, la propriété bénéficiaire directe de la directrice a augmenté à 97 532,9277 actions ; 7 000 actions supplémentaires sont détenues indirectement via le IRA de son conjoint. Le dépôt ne contient aucune transaction dérivée, vente ou achat contre paiement en espèces, indiquant qu’il s’agit d’une attribution de rémunération en actions de routine plutôt que d’une opération motivée par le marché.

À retenir pour l’investisseur : La transaction augmente modestement l’alignement des intérêts des initiés, mais ne signale pas de changement de sentiment ou de fondamentaux pour SLM (symbole : SLM). Étant donné le faible nombre absolu d’actions par rapport aux quelque 250 millions d’actions en circulation de SLM, l’impact sur le marché devrait être négligeable.

Überblick Formular 4: Die unabhängige Direktorin Mary Carter Warren Franke meldete am 17.06.2025 den Erhalt von 5.281 Aktien von eingeschränkten Stammaktien der SLM Corp. im Rahmen des Omnibus-Anreizplans 2021 des Unternehmens. Die Zuteilung, bewertet mit einem Ausübungspreis von $0, stellt einen Teil der jährlichen Vergütung für Direktoren dar und unterliegt den Vesting-Bedingungen, die im Restricted Stock Agreement für unabhängige Direktoren 2025 festgelegt sind. Nach der Zuteilung erhöhte sich das direkte wirtschaftliche Eigentum der Direktorin auf 97.532,9277 Aktien; weitere 7.000 Aktien werden indirekt über das IRA-Konto des Ehepartners gehalten. Die Meldung enthält keine derivativen Transaktionen, Verkäufe oder Käufe gegen Barzahlung, was darauf hinweist, dass es sich um eine routinemäßige aktienbasierte Vergütung handelt und nicht um einen marktgetriebenen Handel.

Investorenausblick: Die Transaktion erhöht die Beteiligung der Insider geringfügig, signalisiert jedoch keine Änderung der Stimmung oder der Fundamentaldaten von SLM (Ticker: SLM). Angesichts der kleinen absoluten Aktienanzahl im Vergleich zu den rund 250 Millionen ausstehenden Aktien von SLM wird der Markteinfluss als unwesentlich eingeschätzt.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Franke Mary Carter Warren

(Last) (First) (Middle)
300 CONTINENTAL DRIVE

(Street)
NEWARK DE 19713

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
SLM Corp [ SLM ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
06/17/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 06/17/2025 A 5,281(1) A $0 97,532.9277(2) D
Common Stock 7,000 I By Spouse's IRA
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. The reporting person received shares of Restricted Common Stock, issued pursuant to the terms of the SLM Corporation 2021 Omnibus Incentive Plan - 2025 Independent Director Restricted Stock Agreement (the "2025 Agreement") in partial payment of the annual retainer to independent directors. The Restricted Common Stock award is subject to vesting upon the terms set forth in the 2025 Agreement.
2. Includes Dividend Equivalent Units issued in connection with Restricted Common Stock held by the reporting person.
Remarks:
/s/ Jeffrey Lipschutz (POA) for Mary Carter Warren Franke 06/20/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many SLM (SLM) shares did the director acquire in this Form 4?

5,281 restricted common shares were granted to Mary Carter Warren Franke on 06/17/2025.

Does the filing involve any insider selling of SLM stock?

No. The transaction is a grant; no shares were sold or disposed of for cash.

What is the director’s total direct ownership after the transaction?

Direct beneficial ownership increased to 97,532.9277 shares.

Are there any indirect holdings disclosed?

Yes. 7,000 shares are held indirectly via the director’s spouse’s IRA.

Is this Form 4 likely to impact SLM’s share price?

Impact is expected to be immaterial because the share count is negligible relative to total shares outstanding.
Slm Corp

NASDAQ:SLM

SLM Rankings

SLM Latest News

SLM Latest SEC Filings

SLM Stock Data

7.08B
207.80M
1.17%
104.54%
5.3%
Credit Services
Personal Credit Institutions
Link
United States
NEWARK